Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Leukemia, Hairy Cell × Trazodone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Hairy Cell 1

Interventions

immunotoxin HA22 3 Cyclophosphamide 2 trametinib 1 polatuzumab vedotin 1 pembrolizumab 1 ontuxizumab 1 ibrutinib 1 fludarabine 1 dabrafenib 1 brexucabtagene autoleucel 1 acalabrutinib 1 Trazodone 1 Rituximab 1 Prednisone 1 PLX8394 1 Lenalidomide 1 HA 22 1 Fentanyl 1 Doxorubicin 1 AGS67E 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05136521 2021-11-29

Bioavailability Study of 300 mg Trazodone Hydrochloride (New Polymer) vs. 300 mg Trazodone Hydrochloride (Contramid® Prolonged-release Tablets) Under Fasting Conditions

Aziende Chimiche Riunite Angelini Francesco S.p.A

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡